Patient preferences and expectations of systemic therapy in renal cell carcinoma.

Authors

null

Dena Battle

KCCure, Alexandria, VA

Dena Battle , Cristiane Decat Bergerot , Pavlos Msaouel , Eric Jonasch , Tian Zhang , Daniel J. George , Michael D. Staehler

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5083)

DOI

10.1200/JCO.2020.38.15_suppl.5083

Abstract #

5083

Poster Bd #

152

Abstract Disclosures

Similar Posters

First Author: Bradley Alexander McGregor

First Author: Takahiro Osawa

Poster

2023 ASCO Genitourinary Cancers Symposium

A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases.

A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases.

First Author: Jianbo Wang

Poster

2019 Genitourinary Cancers Symposium

Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.

Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.

First Author: Yuanyuan Zhang